Table 2 Baseline information of the two groups of patients
Variables | Pre-ERAS | ERAS | P value |
|---|---|---|---|
Age (y) | 68.4 ± 9.5 | 68.7 ± 9.3 | 0.902 |
Sex [n (%)] | 0.904 | ||
Male | 29 (61.7) | 26 (60.5) | |
Female | 18 (38.3) | 17 (39.5) | |
BMI (kg/m2) | 23.9 ± 3.0 | 23.4 ± 2.9 | 0.478 |
Smoking history [n (%)] | 11 (23.4) | 13 (30.2) | 0.464 |
Alcohol history [n (%)] | 7 (14.9) | 4 (9.3) | 0.419 |
Side [n (%)] | |||
Right | 20 (42.6) | 21 (48.8) | 0.550 |
Left | 27 (57.4) | 22 (51.2) | |
Tumor site [n (%)] | 0.509 | ||
Renal pelvis | 20 (42.6) | 23 (53.5) | |
Ureter | 24 (51.1) | 17 (39.5) | |
Both | 3 (6.4) | 3 (7.0) | |
Grade [n (%)] | 0.577 | ||
Low | 11 (23.4) | 8 (18.6) | |
High | 36 (76.6) | 35 (81.4) | |
Tumor size (cm) | 3.5 (2.0,4.0) | 3.5 (2.2,4.5) | 0.408 |
Pathologic T stage [n (%)] | 0.054 | ||
Ta | 4 (8.5) | 2 (4.7) | |
T1 | 4 (8.5) | 10 (23.3) | |
T2 | 12 (25.5) | 3 (7.0) | |
T3 | 22 (46.8) | 25 (58.1) | |
T4 | 5 (10.6) | 3 (7.0) |